Patents for C07K 19 - Hybrid peptides (29,428) |
---|
05/25/1994 | EP0597842A1 Metal binding proteins |
05/25/1994 | EP0597829A1 Novel monoclonal antibody to novel antigen associated with human tumors |
05/24/1994 | US5314995 Antitumor |
05/24/1994 | US5314991 Recombinant 40 KDa Dermatophagoides farinae allergen |
05/24/1994 | CA1329766C T cell epitopes of the hepatitis b virus nucleocapsid protein |
05/18/1994 | EP0597043A1 Porcine adipocyte antigens and their use in the immunological control of fat |
05/18/1994 | EP0335899B1 Immunoaffinity purification system |
05/11/1994 | WO1994010332A1 HUMANIZED ANTIBODIES TO Fc RECEPTORS FOR IMMUNOGLOBULIN G ON HUMAN MONONUCLEAR PHAGOCYTES |
05/11/1994 | WO1994010309A1 Novel p-selectin ligand protein |
05/11/1994 | WO1994009823A1 Urease-based vaccine against helicobacter infection |
05/11/1994 | WO1994009820A1 Prostate-specific membrane antigen |
05/11/1994 | WO1994003620A3 Method of increasing expression of viral proteins |
05/11/1994 | EP0596459A2 Process for purifying recombinant proteins, and use of products thereof |
05/11/1994 | EP0595798A1 Bispecific heteroantibodies with dual effector functions |
05/11/1994 | CA2127283A1 Urease-based vaccine against helicobacter infection |
05/10/1994 | US5310876 Expression of HIV1 and HIV2 polypeptides and their use |
05/10/1994 | US5310663 Affinity peptides |
05/10/1994 | CA1329446C Peptides with laminin activity |
05/10/1994 | CA1329373C Process for recovering refractile bodies containing heterologous proteins from microbial hosts |
05/04/1994 | EP0595659A2 Extracellular matrix receptor ligands that modulate leukocyte function |
05/04/1994 | EP0594843A1 Antibody assay for amylin |
05/04/1994 | EP0594610A1 PROTEIN D - AN IgD-BINDING PROTEIN OF HAEMOPHILUS INFLUENZAE |
05/04/1994 | EP0516655B1 Carrier-bound recombinant protein, process for producing it and its use as an immunogen and vaccine |
05/04/1994 | EP0514413B1 Immunologically active peptides or polypeptides from the parvovirus b19 |
05/04/1994 | EP0413695B1 Chimeric glycoproteins containing immunogenic segments of human parainfluenza virus type 3. |
05/03/1994 | CA1329157C Method for activating gene technologically produced, heterologous, eucaryotic proteins comprising disulphide bridges after expression in procaryotes |
05/01/1994 | CA2109398A1 Extracellular matrix receptor ligands that modulate leukocyte function |
04/28/1994 | WO1994009368A1 Particles having gelatin-aminodextran coatings of and processes for making same |
04/28/1994 | WO1994009131A1 Recombinant specific binding protein |
04/28/1994 | WO1994009034A1 Clot directed anticoagulant, process for making same and methods of use |
04/28/1994 | DE4228457A1 Herstellung von heterodimerem PDGF-AB mit Hilfe eines bicistronischen Vektorsystems in Säugerzellen Production of heterodimeric PDGF-AB using a bicistronic vector system in mammalian cells |
04/28/1994 | CA2146854A1 Recombinant specific binding protein |
04/20/1994 | EP0592480A1 Papillomavirus l2 protein |
04/19/1994 | US5304645 Resorufin derivatives |
04/19/1994 | US5304473 Treating non-insulin dependent diabetes |
04/19/1994 | US5304464 Protein complex enhancing sperm motility |
04/14/1994 | WO1994008241A1 Process for detecting p53-specific antibodies |
04/14/1994 | WO1994008005A1 Novel dna, polypeptide coded for thereby, and method of detecting both |
04/14/1994 | WO1994007921A1 Target binding polypeptide |
04/14/1994 | WO1994007912A1 Affinity purification methods involving amino acid mimetics as elution reagents |
04/14/1994 | WO1993025576A3 Peptides having platelet-derived growth factor (pdgf) activity |
04/14/1994 | CA2146162A1 Affinity purification methods involving amino acid mimetics as elution reagents |
04/14/1994 | CA2124595A1 Process for detecting p53-specific antibodies |
04/13/1994 | EP0592026A1 Method for determining antigenic reactivity in urine |
04/13/1994 | EP0591369A1 Capsid forming and cystein modified chimaeric ms2-coat protein |
04/12/1994 | US5302701 Cell growth promoting activity |
04/12/1994 | US5302697 For controlling secretion of proteins or peptides by genetically engineered saccharomyces culture products |
04/12/1994 | US5302518 In the presence of a heat shock protein |
04/12/1994 | US5302384 Administering to treat inflammation |
04/12/1994 | CA1328419C Receptors for efficient determination of ligands and their antagonists or agonists |
04/06/1994 | EP0590530A2 Fusion proteins for prodrug-activation |
04/06/1994 | EP0590126A1 Polypeptides having kinase activity, their preparation and use |
04/06/1994 | EP0590067A1 Microbially-produced antibody fragments and their conjugates |
04/06/1994 | EP0590058A1 Method for making humanized antibodies |
04/06/1994 | EP0590051A1 Intercellular adhesion molecule-3 and its binding ligands |
04/06/1994 | EP0590011A1 Abrin variants and immunnotoxins |
04/06/1994 | EP0489116B1 Fusion proteins comprising gm-csf and il-3 |
04/05/1994 | US5300631 Antibodies specific for either ras photo-oncogene encoded P21 proteins or ras oncogene encoded P21 proteins but not for both and method of producing same |
03/31/1994 | WO1994006476A1 Method of treating tnf-dependent inflammation using tumor necrosis factor antagonists |
03/31/1994 | WO1994006469A1 Hiv fusion polypeptide |
03/31/1994 | WO1994006456A1 Protection against liver damage by hgf |
03/31/1994 | WO1993023549A3 Nucleic acid corresponding to a gene of chromosome 22 involved in recurrent chromosomal translocations associated with the development of cancerous tumors |
03/30/1994 | EP0589004A1 Process for the determination of peptides corresponding to immunologically important epitopes and their use in a process for determination of antibodies or biotinylated peptides corresponding to immunologically important epitopes, a process for preparing them and compositions containing them |
03/30/1994 | CN1084563A Recombinant DNA molecules encoding aminopeptidase enzymes and their use in the preparation of vaccines against helminth infections |
03/30/1994 | CN1084407A Method for producing clostridium perfringens vaccines |
03/29/1994 | US5298599 Fusion protein |
03/29/1994 | US5298419 Diagnosis |
03/23/1994 | EP0588177A2 An interferon-alpha/beta binding protein, its preparation and pharmaceutical compositions containing it |
03/23/1994 | EP0588036A2 Composition for isolating apamin receptors, apamin binding protein and uses thereof |
03/23/1994 | EP0587806A1 Therapeutic and diagnostic methods based on neurotrophin-4 expression |
03/23/1994 | EP0587555A1 A bifunctional dtpa-type ligand |
03/23/1994 | EP0511978B1 Method of purifying recombinant polypeptides |
03/17/1994 | WO1994005811A1 CLONING AND EXPRESSION OF βAPP-C100 RECEPTOR |
03/17/1994 | WO1994005804A1 Maspin, a novel serpin with tumor suppressing activity |
03/17/1994 | WO1994005786A1 Production of heterodimer pdgf-ab by means of a bicistronic vector system in mammalian cells |
03/17/1994 | WO1993025682A3 Chimeric receptor polypeptides, human h13 proteins and uses thereof |
03/17/1994 | CA2143188A1 Maspin, a novel serpin with tumor suppressing activity |
03/16/1994 | EP0586790A1 Amyloid precursor-like protein and uses thereof |
03/16/1994 | EP0586613A1 Bradykinin antagonists |
03/16/1994 | EP0586505A1 Heteroconjugate antibodies for treatment of hiv infection |
03/15/1994 | US5294538 Enzyme inhibitor |
03/09/1994 | EP0585943A2 Soluble ligands for CD40 |
03/09/1994 | EP0585287A1 Methods for producing members of specific binding pairs |
03/09/1994 | EP0437487B1 Targetting agents |
03/03/1994 | WO1994004688A2 Cationic peptides and method for production |
03/03/1994 | WO1994004686A1 Tat-derived transport polypeptides |
03/03/1994 | WO1994004678A1 Immunoglobulins devoid of light chains |
03/03/1994 | WO1994004674A1 Human melanocyte stimulating hormone receptor |
03/03/1994 | WO1994001451A3 Method for modification of recombinant polypeptides |
03/03/1994 | WO1993023550A3 Activation of oligomerizing receptors by using fused receptor ligands |
03/03/1994 | CA2142306A1 Cationic peptides and method for production |
03/02/1994 | EP0584284A1 Recombinant dna-derived cholera toxin subunit analogs |
03/02/1994 | EP0584251A1 Cytokine receptor targeted molecules for treatment of meoplastic cell growth |
03/02/1994 | EP0584238A1 INHIBITOR OF NF-$g(k)B TRANSCRIPTIONAL ACTIVATOR AND USES THEREOF |
03/02/1994 | EP0584229A1 GLYCAM-1 (Sgp 50), A SELECTIN LIGAND |
03/02/1994 | EP0470980B1 Synthetic peptides for an hiv-1 vaccine |
03/02/1994 | EP0371998B1 Modular assembly of antibody genes, antibodies prepared thereby and use |
03/02/1994 | EP0347433B1 Recombinant antibody |
03/01/1994 | US5290914 Hybrid diphtheria-B.t. pesticidal toxins |
02/23/1994 | EP0583794A1 Recombinant pseudomonas exotoxin: construction of an active immunotoxin with low side effects |